Prescriptions Plus Now Offering Prescription Pain Creams Nationwide for Plantar Fasciitis Relief
Wellington, Florida (PRWEB) May 28, 2014 -- Prescriptions Plus Inc, maker of topical prescription pain creams for numerous painful conditions, is now offering nationwide creams for plantar fasciitis. The prescription pain creams offer direct pain relief with virtually no bloodstream absorption so minimal side effects exist. Call (888) 998-6343 to receive the medication.
Plantar fasciitis affects millions of Americans and leads to chronic heel pain. The pain may last for months or even years and be resistant to conventional treatment methods. The typical treatment options include anti-inflammatories by mouth, steroid injections, night splinting, physical therapy and more.
Prescription pain creams for plantar fasciitis offer several benefits such as direct relief to the area. While the topical cream is absorbed under the skin to the inflamed region, minimal medication is absorbed into the bloodstream. Therefore, no drug interactions occur and no issues with the GI tract or kidneys.
The topical pain cream prescription consists of FDA approved medications that are odor free and much stronger than over the counter options. A recent study by the Patient Outcomes Analysis showed that 83% of patients achieved excellent pain relief with the creams for conditions such as plantar fasciitis, with close to 40% being able to reduce the medications necessary by mouth for relief.
The pain creams are exceptionally beneficial to those suffering from additional conditions such as back pain, tendonitis, neuropathy, RSD, and more.
Prescriptions Plus offers the creams nationwide and performs all the leg work for patients to obtain the prescription and fill it. The pain creams are shipped directly to the patient's home. For those with private insurance and prescription benefits, call Prescriptions Plus at (888) 998-6343 to obtain the prescription creams.
Jon, Prescriptions Plus Inc, http://prescriptionpainreliefcream.com, +1 (888) 998-6343, [email protected]
Share this article